Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Radial spoke head protein 6 homolog A (RSPH6A) is a structural protein encoded by the RSPH6A gene in humans and is a component of the radial spoke head complex in the axoneme of eukaryotic flagella and cilia[1][2][4][5]. RSPH6A and its orthologs are essential for proper assembly and function of the sperm flagellum, where it helps regulate flagellar motility by connecting the central pair of microtubules to the outer doublets and modulating the activity of motor proteins like dynein[2][4][5][7]. RSPH6A is predominantly expressed in the testis and is essential for male fertility in mice; knockout results in short, immotile sperm[4]. Mutations or dysfunction in RSPH6A may contribute to primary ciliary dyskinesia (PCD), a disorder characterized by defective ciliary function, as well as male infertility due to abnormal sperm motility[1][2][4]. There is currently no evidence that RSPH6A is a typical therapeutic target, nor are any drugs or clinical biomarkers associated with it[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radial spoke head protein 6 homolog A (RSPH6A).